Literature DB >> 23229351

(1)H- (31)P soft-HSQC pulse sequence specifically for detecting phosphomono- and diesters in biological samples.

Xi-an Mao1, Bin Jiang, Ling Jiang, Maili Liu.   

Abstract

PURPOSE: Phosphomono- and diesters (PME and PDE) are important metabolites that are potential biomarkers for a number of cancers. We designed a new NMR pulse sequence, i.e., (1)H-(31)P soft-heteronuclear single quantum correlation (HSQC), specifically for noninvasively detecting PME and PDE in biological samples. PROCEDURE: The nonselective (1)H refocusing π pulses in the conventional heteronuclear single quantum correlation pulse sequence are replaced by selective π pulses. When the selective pulses are offset on the CH2O resonances, the homonuclear couplings between the NCH2 and CH2O protons are effectively removed, and the spectrum of PME and PDE is significantly enhanced.
RESULTS: The sensitivity of this pulse sequence has been demonstrated with milk and mouse brain samples. A soft-HSQC spectrum, where only PME and PDE signals appear, can be recorded from these biological samples in minutes with remarkably high signal-to-noise ratio.
CONCLUSION: This pulse sequence provides a new and quick method for in vivo studies of phosphorus metabolite in the human brain and other tissues for medical purposes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23229351     DOI: 10.1007/s11307-012-0607-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  16 in total

Review 1.  Tumour phospholipid metabolism.

Authors:  F Podo
Journal:  NMR Biomed       Date:  1999-11       Impact factor: 4.044

2.  Improve the selectively refocused INEPT pulse sequence for detecting phosphomonoesters and phosphodiesters.

Authors:  Xi-an Mao
Journal:  Magn Reson Med       Date:  2011-12-21       Impact factor: 4.668

3.  Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses.

Authors:  Andrew S Zektzer; Mark G Swanson; Samson Jarso; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

4.  In vivo 14N nuclear magnetic resonance spectroscopy of tumors: detection of ammonium and trimethylamine metabolites in the murine radiation induced fibrosarcoma 1.

Authors:  M P Gamcsik; I Constantinidis; J D Glickson
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

5.  1H-14N HSQC detection of choline-containing compounds in solutions.

Authors:  Jiezhen Mao; Ling Jiang; Bin Jiang; Maili Liu; Xi-an Mao
Journal:  J Magn Reson       Date:  2010-06-09       Impact factor: 2.229

Review 6.  Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.

Authors:  Kristine Glunde; Ellen Ackerstaff; Noriko Mori; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

7.  31P magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono- and diesters at 3 T in the human brain: relation with age and spatial differences.

Authors:  J P Wijnen; T W J Scheenen; D W J Klomp; A Heerschap
Journal:  NMR Biomed       Date:  2010-10       Impact factor: 4.044

8.  Nondestructive observation of bovine milk by NMR spectroscopy: analysis of existing States of compounds and detection of new compounds.

Authors:  Fangyu Hu; Kazuo Furihata; Mie Ito-Ishida; Shuichi Kaminogawa; Masaru Tanokura
Journal:  J Agric Food Chem       Date:  2004-08-11       Impact factor: 5.279

9.  Comparison of polarization transfer sequences for enhancement of signals in clinical 31P MRS studies.

Authors:  Laura Mancini; Geoffrey S Payne; Martin O Leach
Journal:  Magn Reson Med       Date:  2003-09       Impact factor: 4.668

10.  3D RINEPT {1H}-31P CSI: a feasible approach for the study of membrane turnover in the human brain.

Authors:  Tim Wokrina; Marco Ulrich; Wolfgang Weber-Fahr; Gabriele Ende
Journal:  Magn Reson Med       Date:  2008-05       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.